The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 has awarded Revance Therapeutics, Inc., a for-profit organization, an Interim Agreement under Federal Supply Schedule (FSS) 65 I B Drugs, Pharmaceuticals, & Hematology Related Products. This is a Multiple Award contract with a potential value of $25,000.00 and a period of performance running through May 14, 2024.
The contract aims to procure pharmaceutical products and related services. While the specific details of the task orders or price lists were not provided, the FSS 65 I B schedule indicates that the contracted products and services are likely in the drugs, pharmaceuticals, and hematology-related categories. As a Department of Veterans Affairs contract, the products and services will be utilized to support the VA's healthcare mission and serve eligible veterans.
Generated 4/23/24, 3:34 PM